Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSQKlJZsC1cbaDanVGAVt2ktlkqOYuXZ6tindp59DqJZOydqa+g1s5+7i+/vnv5Kcbm+ZtwGUVPCB3wki3wOeiozym4E/n523Y/902ErWZEMqy/pBFHS6vpcyIuXAL2aDBRAugx+XF5/APA/oD1teIhZrSNWTdVpRFnwhcnVJ8mKNl2wEzbxbUCuRDfxcq92ol0iFporhvcBfMicpJOF+pDq7vu5Vx5OwCPaCqFoCXhB+Uxt0iVYxU40IXI2IghuBD/Wh0+tu3D+JotgqBZVTkEJjChOiVhMUG5pBVp+JMAlWSZb32RXghoEqktQGD9fprbQKTtZkO4W7cX3RH8zsSG1VO2p3+ie946Ooe9KN4q5VKqxsVb14zEuEeY7ZdfddfHwU98MlhhkKBrkivG1+5YA0E8yyVxOBijBHXaJy9FRvjvIg3D2rhozKnJGHYC1z260iSMw0oKGCuxcp3mCGhlPM7Nk/8blmLHxl1fM9RRxVXEBqJDRXDTA5n9puxEhwBdvmjtrxT233WqQg3y7sb8Hr2T/RC0ZTW8QZCGmQaj4dNxPOJRw+EglzdEeH75Rn4l6+PXWqXXZUfb4D538u0F4cx9ZH6qcRVMP9c6aLtoaGRlQeApkxX4pD8WI0Wh/qUaHOxLkzRyIlDBrsUduSPEaVj27Ome7dnalyojbo57OZrVy+acCHq93f2tA0G1QbbUdmF7g3+mys/fVqL4/8C7xzLz6ys4Ma64myUiqX78NwRWRbErNRgTlLrulfuYDduXgnt3zpekqGOip9UV6NL++W7dl7zgMc6mv3z+/9c20OhRoO6EOJaWcwHZ+9PZ//mlpnZU+ewMRdmp0BJYoK7soI6UVtxINvBNNafo6GD1+XS9rwbaVRmklYftcZtpKw+KYzbP0BNcQBdQ==
uAZ9fcTtF1CeHYLN